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Abstract 
We assessed whether radon inhalation inhibited carrageenan-induced inflammation in mice. 
Carrageenan (1% v/v) was injected subcutaneously into paws of mice that had or had not 
inhaled approximately 2000 Bq/m3 of radon for 24 hr. Radon inhalation significantly 
increased superoxide dismutase (SOD) and catalase activity and significantly decreased lipid 
peroxide levels in mouse paws, indicating that radon inhalation activate antioxidative 
functions. Carrageenan administration induced paw edema and significantly increased tumor 
necrosis factor-alpha (TNF-α) and nitric oxide in serum. However, radon inhalation 
significantly reduced carrageenan-induced paw edema. Serum TNF-α levels were lower the 
radon-treated mice than in sham-treated mice. In addition, SOD and catalase activity in paws 
were significantly higher in the radon-treated mice than the sham-treated mice. These findings 
indicated that radon inhalation had anti-inflammatory effects and inhibited 
carrageenan-induced inflammatory paw edema. 
 
 
 
Keywords: radon inhalation; inflammation; carrageenan; edema; antioxidative 
function 
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INTRODUCTION 
Low-dose irradiation induces various positive effects, especially activation of antioxidative 
[1-5] and immune functions [6,7]. Low-dose X- or γ-irradiation activates antioxidative 
functions in some organs and, consequently, inhibits oxidative injury [8-13]. In mice for 
example, pretreatment with low-dose X-irradiation inhibits carbon tetrachloride 
(CCl4)-induced hepatopathy [8] and treatment with low-dose (0.5 Gy) X-irradiation following 
exposure to CCl4 reduced the oxidative damage associated with CCl4-induced hepatopathy. [9]. 
In addition, low-dose X-irradiation inhibits brain edema induced by cold injury [14] and paw 
edema induced by ischemia-reperfusion injury [11]. It is highly possible that low-dose 
X-irradiation activates the defensive systems in the living body and, therefore, contributes to 
preventing or reducing reactive oxygen species (ROS)-related injuries, which are thought to 
involve peroxidation.  
Therapy involving radon gas volatilized from radon-enriched water is performed for various 
diseases at Misasa Medical Center, Okayama University Hospital. Most conditions treated 
with radon therapy are lifestyle-related diseases, such as arteriosclerosis, osteoarthritis [15], 
and bronchial asthma [16]. To assess the effects of radon, we have co-developed a 
radon-exposure system for small animals (OZ PLAN Co., Ltd. Okayama, Japan); using this 
system we demonstrated that radon inhalation activated antioxidative functions in the liver, 
kidney, lung, and brain of mice [17]. These findings indicate that radon inhalation may be 
used as a treatment for liver, kidney, lung, and brain damage. Recently, we also demonstrated 
that radon inhalation inhibits the oxidative damage associated with CCl4-induced hepatopathy 
in mice, indicating that radon inhalation has antioxidative effects [18].  
Reportedly, low-dose X- and γ-irradiation each have anti-inflammatory effects. For example, 
low-dose γ-irradiation attenuates collagen-induced arthritis through suppression of 
pro-inflammatory cytokines and autoantibody production and through induction of regulatory 
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T cells [19]. Moreover, radiation, even at low-doses, functionally modulates inflammatory 
cells, and the mechanism by which low-dose radiation exerts anti-inflammatory effects may 
involve heat shock proteins [20]. However, there have been no reports on anti-inflammatory 
effects of radon inhalation in mice. 
The purpose of this study was to determine whether radon inhalation has anti-inflammatory 
effects in mice. We examined the following biochemical and histological parameters to assess 
the effects of radon treatment on antioxidative and anti-inflammatory responses: superoxide 
dismutase (SOD) activity, catalase activity, total glutathione content (t-GSH), lipid peroxide 
levels, tumor necrosis factor-alpha (TNF-α), nitric monoxide (NO), and paw histology. 
 
MATERIALS AND METHODS 
Radon inhalation system 
The radon inhalation system is shown in Fig. 1 A. To generate conditions for inhalation of a 
specific concentration, approximately 100 kg of the “Doll Stone” radon source (Ningyotoge 
Gensiryoku Sangyo, Co., Ltd. Okayama, Japan) was placed in a radon tank. Air with radon 
was blown into the mouse cages from the tank at a rate of 2.5 L/min/cage. Odor was removed 
with a high efficiency particulate air (HEPA) filter, and we ensured sufficient oxygen levels in 
the mouse cages by fresh air intake. As shown in Fig.1 A, the air with radon in the mouse 
cages was returned to the radon tank, and some air was then released through the exhaust air 
duct. The volume was controlled by an air displacement pump. 
The radon concentrations in the mouse cage are shown in Fig.1 B and C. Radon 
concentration in mouse cage was controlled by changing the number of Doll stone and the 
volume of the outlet flow through exhaust air duct. The radon concentration in the mouse cage 
was measured using a radon monitor (CMR-510, femto-TECH INC., Ohio, USA). The mean 
concentrations of background radon and treatment radon were approximately 15 Bq/m3 and 
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2000 Bq/m3, respectively.  
 
Animals 
Female ICR mice (age, 8 weeks; body weight, approximately 28 g) were obtained from the 
Charles River Laboratories Japan Inc. (Yokohama, Japan). Ethical approval for all protocols 
and experiments was obtained from the animal experimental committee of Okayama 
University. Mice inhaled radon at a concentration of 2000 Bq/m3 for 24 hr. Mice had free 
access to food and water during radon inhalation and the sham treatment. Carrageenan was 
dissolved physiological saline solution (50 µl of 1% v/v) and was injected in to the right 
hindpaw of the mice immediately after radon inhalation. Paw volume was assessed by 
comparing paws before and after injection with carrageenan. Paw volumes were measured at 0, 
1, 2, 3, 4, or 5 hr after carrageenan administration by measuring the changes in water levels 
and total volume associated with bathing mouse paws in water-filled container. To assess the 
effects of radon inhalation, mice were separated into two groups that were treated with 
air-only (sham) or radon inhalation, and then all mice in both groups were injected with 
carrageenan solution. Two hours after injection, blood was drawn from the heart for serum 
analysis, and paws were quickly excised. Serum was separated from the blood samples by 
centrifugation at 3,000 × g for 5 min for the SOD activity, t-GSH content, NO, and TNF-α 
assays. These samples were preserved at -80 °C until use. Paw tissue samples were fixed in 
10% neutral-buffered formalin and decalcified with Plank-Rychlo solution for histological 
examinations.  
 
Biochemical assays 
NO levels were measured using the NO2/NO3 assay Kit C II (Dojindo Molecular 
Technologies, Inc., Kumamoto, Japan) according to the manufacturer’s recommendations. 
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This assay is based on the azo coupling reaction between diazonium salt compound and 
naphthy ethylenediamine. The optical density of the colored products was read at 540 nm in a 
spectrophotometer and was directly proportional to the NO level.  
Serum TNF-α was measured by a enzyme-linked immunosorbent assay (ELISA) using the 
Mouse TNF-α ELISA KIT (Shibayagi Co., Ltd Gunma, Japan) according to the manufacturer’s 
recommendations. 
Mouse paws were homogenized in a 10 mM phosphate buffer (PBS; pH 7.4), on ice. The 
homogenates were centrifuged at 12,000 × g for 45 min at 4 °C and the supernatants were used 
for assay of the activity of SOD and catalase. 
SOD activity was measured by the nitroblue tetrazolium (NBT) reduction method [21] 
using the Wako-SOD test (Wako Pure Chemical Industry, Co., Ltd., Osaka, Japan) according 
to the manufacturer’s recommendations. Briefly, the extent of inhibition of the reduction in 
NBT was measured at 560 nm using a spectrophotometer. One unit of enzyme activity was 
defined as 50% inhibition of NBT reduction. 
Catalase activity was measured as the hydrogen peroxide (H2O2) reduction rate at 37 °C and 
was assayed at 240 nm H2O2 using a spectrophotometer [22]. The assay mixture consisted of 
50 μl of 1 M Tris-HCl buffer containing 5 mM ethylenediaminetetraacetic acid (pH 7.4), 900 
μl of 10 mM H2O2, 30 μl deionized water, and 20 μl paw supernatant. Activity was calculated 
using a molar extinction coefficient of 7.1×10−3 M−1cm−1. Catalase activity was measured by 
the amount of hydrogen peroxide split by catalase at 37 °C. The reactions were started by 
addition of the supernatant. 
Total glutathione content was measured using the Bioxytech GSH-420TM assay kit (OXIS 
Health Products, Inc., Portland, OR, USA) according to the manufacturer’s recommendations. 
Briefly, tissue samples from paw were suspended in 10 mM PBS (pH 7.4), mixed with 
ice-cold 7.5% trichloroacetic acid solution, and homogenized. The homogenates were 
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centrifuged at 3,000 × g for 10 min. The supernatants or serum were used for the assay. This 
assay is based on the formation of a chromophoric thione the absorbance of which can be 
measured at 420 nm and is directly proportional to the total glutathione concentration.  
Lipid peroxide levels were assayed using the Bioxytech LPO-586TM assay kit (OXIS Health 
Products, Inc.) according to the manufacturer’s recommendations. Briefly, paw samples were 
homogenized in 10 mM PBS (pH 7.4) on ice. Prior to homogenization, 10 μL of 0.5 M 
butylated hydroxytoluene in acetonitrile were added per 1 mL of the buffer-tissue mixture. 
After homogenization, the homogenate was centrifuged at 15,000 × g, for 10 min at 4 °C, and 
the supernatant was used for the assay. The lipid peroxide level assay is based on the reaction 
of a chromogenic reagent, N-methyl-2-phenylidole, with malondialdehyde and 
4-hydroxyalkenals at 45 °C. The optical density of the colored products was read at 586 nm in 
a spectrophotometer. 
The protein content in each sample was measured by the Bradford method, using Protein 
Quantification Kit-Rapid (Dojindo Molecular Technologies, Inc., Kumamoto, Japan) [23].  
 
Histological examination 
Paw samples were fixed in 10% formalin, and decalcified with Plank-Rychlo solution. 
Fixed, decalcified specimens were dehydrated in a graded ethanol and xylene series and then 
embedded in paraffin. Tissue sections (6 microns) were prepared and stained with 
hematoxylin-eosin (HE). 
 
Statistical analyses 
The data values are presented as the mean ± standard error of the mean (SEM). Each 
experimental group consisted of samples from 6-7 animals. The statistical significance of 
differences was determined by Student's t-test for comparisons between two groups and 
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Tukey’s tests for multiple comparisons where appropriate. P-values were considered 
significant at P<0.05.  
 
RESULTS 
Effect of radon inhalation on paw edema induced by carrageenan 
  Mean paw volume increased of approximately 0.07 ml after injection with carrageenan. 
However, carrageenan-induced paw edema was significantly reduced by treatment with radon 
at every time point following carrageenan injection (Fig. 2). 
 
Effects of radon inhalation on TNF-α, NO, or antioxidative function in serum 
  To assess the effects of radon inhalation on the anti-inflammatory response following 
carrageenan injection, serum levels of NO and TNF-α were measured after mice were exposed 
to a sham or radon inhalation treatment; similarly, the levels of antioxidative enzymes, e.g., 
SOD, were measured in serum and paw-tissue samples to assess the effects of radon inhalation 
on antioxidative functions. There were no significant differences in mean serum TNF-α and 
NO concentrations between the sham and radon-treated groups (Fig. 3 A and B). Serum SOD 
activity was significantly higher in the mice exposed to radon than in sham-treated mice (Fig. 
3 C). Similarly, SOD and catalase activity was significantly higher in paws from radon-treated 
mice than in paws from sham-treated mice; in contrast, the lipid peroxide levels were 
significantly lower in paws from radon–treated mice than in paws from sham-treated mice 
(Fig. 3 D). 
 
Effects of radon inhalation on NO in mice serum following carrageenan administration 
In mice that had not be pretreated with radon, serum NO levels were significantly higher in 
carrageenan-injected mice than in control mice (sham versus control; Fig. 4). However, in 
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mice that had been injected with carrageenan, serum NO levels were 33% lower in 
radon-treated mice than in sham-treated mice, but this difference was not statistically 
significant (2000 Bq/m3 versus sham; Fig. 4). 
 
Histological observation in paws following carrageenan administration 
   Carrageenan administration increased inflammatory leukocytes in paw in the presence or 
absence of radon inhalation (Fig.5 A, B, C, D). No significant differences were observed in 
inflammatory leukocytes between control group and radon inhalation group (Fig. 5 A, B, E). 
However, there were significantly fewer inflammatory leukocytes per unit area in paws from 
the radon-treated group than in paws from the sham-treated group (Fig. 5E).  
 
Effects of radon inhalation on the TNF-α in mouse serum following carrageenan 
administration 
To assess the anti-inflammatory effect of radon inhalation, serum TNF-α levels were 
measured. In mice that had not been pretreated with radon, serum TNF-α levels were 
significantly higher in animals injected with carrageenan than in control animals (sham versus 
control; Fig. 6). In animals injected with carrageenan, serum TNF-α levels were significantly 
higher in sham-treated animals than in radon-treated animals (2000 Bq/m3 versus sham; Fig. 
6). 
 
Effects of radon inhalation on oxidative damage levels in mouse serum and paws following 
carrageenan administration 
  To assess the protective effects of radon inhalation on carrageenan-induced inflammation, 
various parameters of oxidative damage were assayed in serum and paw-tissue samples 
following sham or radon treatments.  
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SOD activity in serum from the group pretreated with radon was significantly higher than 
that from the carrageenan-administrated group (2000 Bq/m3 versus sham; Fig. 7 A). The mean 
lipid peroxide level in paws was 20% higher in mice injected with carrageenan, but not treated 
with radon, than in control animals, but this difference was not significant (sham versus 
control; Fig. 7 B). However, lipid peroxide levels in paws were 16% lower in radon-treated 
animals than in sham-treated animals following carrageenan injection, but this difference was 
not significant (2000 Bq/m3 versus sham; Fig. 7 B).  
In mice that had not be pretreated with radon, SOD and catalase activity and t-GHS 
contents were significantly lower in paws from carrageenan-injected mice than in paws from 
control mice (sham versus control; Fig. 7A). In mice had been injected with carrageenan, SOD 
and catalase activity were significantly higher in paws from radon-treated mice than in paws 
from sham-treated mice (2000 Bq/m3 versus sham; Fig. 7A).  
 
DISCUSSION 
Radon therapy is performed for various diseases, such as ankylosing spondylitis, chronic 
polyarthritis, spondylosis deformans, osteoarthritis [15], and bronchial asthma [16], at Misasa 
Medical Center, Okayama University Hospital. Hepatic and renal damage are not the primary 
indications for radon therapy. However, we have shown previously that radon inhalation 
activates antioxidative functions in liver, kidney, lung, and brain of mice [17], and our results 
demonstrate that radon inhalation clearly inhibits oxidative damage in the liver and kidney of 
mice [18]. It is highly possible that radon inhalation activates defensive systems and, 
therefore, contributes to preventing or reducing ROS-related injuries, which are thought to 
involve peroxidation. The present study showed that antioxidative functions were 
significantly higher in mice that had inhaled radon at a concentration of 2000 Bq/m3 for 24 hr 
than in control mice. 
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Most conditions treated with radon therapy are pain-related diseases such as osteoarthritis 
[15] and rheumatoid arthritis [24]. Another research group reported that radon inhalation 
significantly increased β-endorphin and M-enkephalin which both have morphine-like 
analgesic effects [25]. In addition, it has been reported that low-dose γ-irradiation attenuates 
collagen-induced arthritis through suppression of pro-inflammatory cytokines and 
autoantibody production and through induction of regulatory T cells [19]. To assess the 
anti-inflammatory effects of radon inhalation, we used a carrageenan-induced inflammation 
model. Our results showed that carrageenan-induced paw edema was significantly reduced by 
treatment with radon at every time point measured, indicating that radon inhalation had 
anti-inflammatory effects similar to those of X- or γ-irradiation.  
Cuzzocrea suggests that some of the delayed inflammatory pathways involving nitric oxide 
(NO•), superoxide (O2•), hydroxyl radical (•OH), and peroxynitrite (ONOO•) are induced in 
carrageenan-induced inflammation [26]. Carrageenan triggers the expression of the inducible 
NO synthase (iNOS), a process that occurs, at least in part, via activation of nuclear factor kB 
(NF-kB). NO, in turn, combines with O2• to yield ONOO•. The •OH and ONOO• radicals 
induce cellular injury. ROSs, such as NO•, O2•, •OH, and ONOO•, were caused by oxidative 
damage and induced paw edema. To assess the mechanisms mediating the anti-inflammatory 
effects associated with radon inhalation, we first examined the NO level in serum. Our results 
indicated that the inhibition of NO synthesis contributed to the reduction in 
carrageenan-induced inflammation.  
Cuzzocrea also suggests that the polymorphonuclear leukocyte infiltration and activation 
induced O2• and H2O2 production. In this study, our results showed that carrageenan 
administration increased infiltration of inflammatory leukocyte in paw in the presence or 
absence of radon inhalation. However, the number of inflammatory leukocytes in paw was 
significantly lower in the radon-treated group than in the carrageenan-administrated, 
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sham-treated mice. These findings may indicate that radon inhalation reduced ROS production 
induced by carrageenan administration. 
Next, we examined serum TNF-α levels. TNF-α is major mediator in the inflammatory 
response and a mediator of carrageenan-induced inflammatory incapacitation. Moreover, 
TNF-α is able to induce the further release of kinins and leukotrienes, which may have an 
important role in the maintenance of long-lasting nociceptive responses [27]. Serum TNF-α 
levels were significantly lower in the radon-treated group than in the 
carrageenan-administrated, sham-treated group. These findings indicated that radon inhalation 
inhibited the inflammation induced by carrageenan. 
We previously reported that low-dose X-irradiation in mice inhibited paw edema following 
ischemia-reperfusion [11] and brain edema following cold injury [14]. These reports may 
indicate that low-dose irradiation activates antioxidative function, especially SOD activity, 
which catalyzes the conversion of O2• into H2O2. In this study, our data showed that radon 
inhalation inhibited paw edema induced by carrageenan. To further clarify the mechanisms 
that inhibited paw edema, antioxidative functions (i.e., lipid peroxide levels, total glutathione 
content, and SOD and catalase activity) were investigated. The SOD and catalase activity in 
paws was significantly higher in the radon-treated group in the carrageenan-administrated 
sham-treated group; these findings indicated that radon inhalation activated antioxidative 
functions and inhibited carrageenan-induced inflammatory paw edema. These findings also 
indicated that radon had the same effects as low-dose X-irradiation. 
Radon therapy is performed for pain-related diseases at Misasa Medical Center, Okayama 
University Hospital and Badgastein in Austria. Our present study demonstrated that radon 
inhalation has anti-inflammation effects. However, our study did not assess whether radon 
inhalation reduced the pain associated with inflammation. The data presented in this study 
provide a substantial basis for future studies aimed at assessing relief from pain induced by 
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inflammation. 
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Figure Legends 
 
Fig. 1 Schematic diagram of the radon exposure system (A). Changes in radon concentration 
in mouse cages due to outlet flow (B) or the number of Doll Stones (C). (D) Changes in 
the radon concentration in the mouse cage over the period of radon inhalation. 
Fig. 2 Effect of radon inhalation on carrageenan-induced paw edema. Each value indicates the 
mean paw volume ± SEM. The number of mice per experimental point was 6-7. *P < 
0.05, **P < 0.01, ***P < 0.001 vs Sham. 
Fig. 3 Changes in serum levels of TNF-α (A), NO (B), and antioxidant-associated parameters 
(C), and antioxidant-associated parameters (D) in paw. Each value indicates the mean ± 
SEM. Each experimental point represents data from 6-7 mice. *P < 0.05, **P < 0.01, 
***P < 0.001 vs Control.  
Fig. 4 Effects of radon inhalation on serum NO levels of carrageenan-administrated mice. 
Each value indicates the mean ± SEM. Each experimental point represents data from 7 
mice. *P < 0.05 vs Control. 
Fig. 5 Histological changes in mouse paw after carrageenan administration. Mouse paws were 
examined histologically. (A) Control, (B) radon inhalation, (C) carrageenan 
administration, (D) radon inhalation before carrageenan administration. The length of 
the scale bar is 50 μm. All samples were stained with HE. (E) Fewer inflammatory 
leukocytes infiltrated tissues of the mice pretreated with radon than of those treated only 
with carrageenan administration. Each value indicates the mean ± SEM. Each 
experimental point represents data from 6 mice. ***P<0.001 vs control, #P<0.05 vs 
radon inhalation before carrageenan administration. 
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Fig. 6 Effects of radon inhalation on serum TNF-α levels in carrageenan-administrated mice. 
Each value indicates the mean ± SEM. Each experimental point represents data from 6-7 
mice. **P < 0.01 vs Control, ##P < 0.01 vs Sham. 
 
Fig. 7 Effects of radon inhalation on antioxidant-associated parameters in serum (A) and in 
paws (B) of carrageenan-administrated mice. Each value indicates the mean ± SEM. 
Each experimental point represents data from 6-7 mice. **P < 0.01, ***P < 0.001 vs 
Control, #P < 0.05, ##P < 0.01 vs Sham. 
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Fig.6  
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